Mjardin Group Stock Price, News & Analysis
Company Description
Mjardin Group (OTC Link: MJARF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $9.0K.
This page provides a comprehensive overview of MJARF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mjardin Group (MJARF) stock last traded at $0.0000. At a market capitalization of $9.0K, MJARF is classified as a micro-cap stock with approximately 90.1M shares outstanding.
Latest News
Mjardin Group has 9 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include management. View all MJARF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Mjardin Group (MJARF) currently stands at 23.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 99.7 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Mjardin Group (MJARF) currently stands at 99.7 days, down 90% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 90% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
MJARF Company Profile & Sector Positioning
Mjardin Group (MJARF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MJARF often look at related companies in the same sector, including Priority Aviat (PJET), Item 9 Labs (INLB), Avivagen (VIVXF), Industry Source Consulting Inc (INSO), and Wowi (WOWU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MJARF's relative position within its industry.